Boston Scientific reviews

The management is short-sighted. Frequently laying off people

Cronyism runs rampant throughout this company from the days of Schneider and Scimed. Few new people and fewer new ideas. Top heavy organization and middle to upper management is stagnant. Working-leveling employees are not trusted or empowered to make decisions. Projects are generally are poorly managed, micro-managed, and timelines are unrealistic. Business model is shifting to acquisition based growth instead of organic development which is a waste of the talent the company does have. Significant benefit erosion and unwillingness/lack of effort to retain top talent. 2012 annual merit increase for average employee was 0%, second time since 2007. Top talent has been leaving in droves and layoffs seem to be an annual occurrence since 2007. Far too risk averse in the process of deciding and funding new product development puts the company in a constant catch-up mode with the competition. Sales force and marketing strategy are poor at best. Company does not execute on its proclaimed values.